NO311604B1 - Blanding for biomaterial og fremgangsmåte for fremstilling derav - Google Patents
Blanding for biomaterial og fremgangsmåte for fremstilling derav Download PDFInfo
- Publication number
- NO311604B1 NO311604B1 NO19980504A NO980504A NO311604B1 NO 311604 B1 NO311604 B1 NO 311604B1 NO 19980504 A NO19980504 A NO 19980504A NO 980504 A NO980504 A NO 980504A NO 311604 B1 NO311604 B1 NO 311604B1
- Authority
- NO
- Norway
- Prior art keywords
- mixture
- polymer
- liquid phase
- sterile
- stated
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 78
- 239000012620 biological material Substances 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title claims description 4
- 238000000034 method Methods 0.000 title claims description 3
- 230000008569 process Effects 0.000 title description 2
- 239000007791 liquid phase Substances 0.000 claims abstract description 21
- 239000012071 phase Substances 0.000 claims abstract description 19
- 239000001506 calcium phosphate Substances 0.000 claims abstract description 18
- 239000002245 particle Substances 0.000 claims abstract description 13
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims abstract description 11
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims abstract description 11
- 239000007864 aqueous solution Substances 0.000 claims abstract description 9
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims abstract description 9
- 229940078499 tricalcium phosphate Drugs 0.000 claims abstract description 9
- 229920000249 biocompatible polymer Polymers 0.000 claims abstract description 8
- 238000006467 substitution reaction Methods 0.000 claims abstract description 6
- 229920000642 polymer Polymers 0.000 claims description 45
- 239000011575 calcium Substances 0.000 claims description 8
- 229920002678 cellulose Polymers 0.000 claims description 8
- 239000001913 cellulose Substances 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 229920003086 cellulose ether Polymers 0.000 claims description 6
- PSKMQMATIKSZEV-UHFFFAOYSA-H calcium titanium(4+) diphosphate Chemical compound [Ca+2].[Ti+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O PSKMQMATIKSZEV-UHFFFAOYSA-H 0.000 claims description 5
- 238000002513 implantation Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 239000010936 titanium Substances 0.000 claims description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- 150000001340 alkali metals Chemical class 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 125000000524 functional group Chemical group 0.000 claims description 4
- 239000004593 Epoxy Substances 0.000 claims description 3
- 239000003125 aqueous solvent Substances 0.000 claims description 3
- 239000012298 atmosphere Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 229920002907 Guar gum Polymers 0.000 claims description 2
- ANUVOLVNLJAALL-UHFFFAOYSA-N N.O[SiH3] Chemical compound N.O[SiH3] ANUVOLVNLJAALL-UHFFFAOYSA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 238000006266 etherification reaction Methods 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 239000002243 precursor Substances 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 abstract description 13
- 229910019142 PO4 Inorganic materials 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 235000019731 tricalcium phosphate Nutrition 0.000 abstract description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 9
- 238000004132 cross linking Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 8
- 229910000389 calcium phosphate Inorganic materials 0.000 description 7
- 239000000945 filler Substances 0.000 description 7
- 239000012764 mineral filler Substances 0.000 description 7
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 6
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 5
- 229910000077 silane Inorganic materials 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 4
- 125000005372 silanol group Chemical group 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000000399 orthopedic effect Effects 0.000 description 3
- BPSIOYPQMFLKFR-UHFFFAOYSA-N trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](OC)(OC)CCCOCC1CO1 BPSIOYPQMFLKFR-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 230000033558 biomineral tissue development Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- -1 phosphocalcium Chemical compound 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000000518 rheometry Methods 0.000 description 2
- 230000037390 scarring Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- UDHXJZHVNHGCEC-UHFFFAOYSA-N Chlorophacinone Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)C(=O)C1C(=O)C2=CC=CC=C2C1=O UDHXJZHVNHGCEC-UHFFFAOYSA-N 0.000 description 1
- 241000766026 Coregonus nasus Species 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 1
- 241000124236 Lentula Species 0.000 description 1
- 241000906034 Orthops Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 208000037873 arthrodesis Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229920005601 base polymer Polymers 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000005312 bioglass Substances 0.000 description 1
- 239000003364 biologic glue Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000316 bone substitute Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000011243 crosslinked material Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000010954 inorganic particle Substances 0.000 description 1
- 229920000554 ionomer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 210000001595 mastoid Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910001463 metal phosphate Inorganic materials 0.000 description 1
- ARYZCSRUUPFYMY-UHFFFAOYSA-N methoxysilane Chemical group CO[SiH3] ARYZCSRUUPFYMY-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002557 mineral fiber Substances 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 150000003961 organosilicon compounds Chemical class 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicinal Preparation (AREA)
- Prostheses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9509582A FR2737663B1 (fr) | 1995-08-07 | 1995-08-07 | Composition pour bio-materiau, procede de preparation |
| PCT/FR1996/001196 WO1997005911A1 (fr) | 1995-08-07 | 1996-07-29 | Composition pour bio-materiau, procede de preparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO980504D0 NO980504D0 (no) | 1998-02-05 |
| NO980504L NO980504L (no) | 1998-04-06 |
| NO311604B1 true NO311604B1 (no) | 2001-12-17 |
Family
ID=9481764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19980504A NO311604B1 (no) | 1995-08-07 | 1998-02-05 | Blanding for biomaterial og fremgangsmåte for fremstilling derav |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6001394A (ja) |
| EP (1) | EP0843562B1 (ja) |
| JP (1) | JP3597541B2 (ja) |
| AT (1) | ATE214292T1 (ja) |
| AU (1) | AU707039B2 (ja) |
| CA (1) | CA2226304C (ja) |
| DE (1) | DE69619830T2 (ja) |
| DK (1) | DK0843562T3 (ja) |
| ES (1) | ES2173306T3 (ja) |
| FR (1) | FR2737663B1 (ja) |
| NO (1) | NO311604B1 (ja) |
| PT (1) | PT843562E (ja) |
| WO (1) | WO1997005911A1 (ja) |
| ZA (1) | ZA966635B (ja) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6417247B1 (en) * | 1997-10-14 | 2002-07-09 | Beth L. Armstrong | Polymer/ceramic composites |
| US20020095157A1 (en) | 1999-07-23 | 2002-07-18 | Bowman Steven M. | Graft fixation device combination |
| US6179840B1 (en) | 1999-07-23 | 2001-01-30 | Ethicon, Inc. | Graft fixation device and method |
| US6599516B1 (en) | 2000-09-14 | 2003-07-29 | Etex Corporation | Malleable implant containing solid element that resorbs or fractures to provide access channels |
| US6800245B1 (en) * | 2000-11-28 | 2004-10-05 | Vita Special Purpose Corporation | Sterile polymerizable systems and kits and methods of their manufacture and use |
| CA2365376C (en) * | 2000-12-21 | 2006-03-28 | Ethicon, Inc. | Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
| US6852330B2 (en) | 2000-12-21 | 2005-02-08 | Depuy Mitek, Inc. | Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration |
| US6599323B2 (en) | 2000-12-21 | 2003-07-29 | Ethicon, Inc. | Reinforced tissue implants and methods of manufacture and use |
| US20030091971A1 (en) * | 2001-09-14 | 2003-05-15 | Invitrogen Corporation | Composition for stabilizing biological materials |
| WO2003080119A1 (en) * | 2002-03-26 | 2003-10-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Responsive biomedical composites |
| JP3806061B2 (ja) * | 2002-05-21 | 2006-08-09 | 富士通株式会社 | 金属修飾アパタイト含有膜の形成方法、これに用いられるコーティング液、および金属修飾アパタイト含有膜で被覆された部位を有する電子機器 |
| WO2004014452A2 (en) * | 2002-08-12 | 2004-02-19 | Osteotech, Inc. | Synthesis of a bone-polymer composite material |
| AU2002328444A1 (en) * | 2002-09-17 | 2004-04-08 | Fujitsu Limited | Photocatalyst apatite-containing film, method of forming the same, coating fluid, and electronic apparatus having member covered with photocatalyst apatite-containing film |
| US7824701B2 (en) | 2002-10-18 | 2010-11-02 | Ethicon, Inc. | Biocompatible scaffold for ligament or tendon repair |
| US20040078090A1 (en) | 2002-10-18 | 2004-04-22 | Francois Binette | Biocompatible scaffolds with tissue fragments |
| US20050251267A1 (en) * | 2004-05-04 | 2005-11-10 | John Winterbottom | Cell permeable structural implant |
| FR2850282B1 (fr) | 2003-01-27 | 2007-04-06 | Jerome Asius | Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation |
| WO2004069890A2 (en) | 2003-02-04 | 2004-08-19 | Osteotech, Inc. | Polyurethanes for osteoimplants |
| US7985414B2 (en) * | 2003-02-04 | 2011-07-26 | Warsaw Orthopedic, Inc. | Polyurethanes for osteoimplants |
| US8197837B2 (en) | 2003-03-07 | 2012-06-12 | Depuy Mitek, Inc. | Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof |
| US8226715B2 (en) | 2003-06-30 | 2012-07-24 | Depuy Mitek, Inc. | Scaffold for connective tissue repair |
| US10583220B2 (en) | 2003-08-11 | 2020-03-10 | DePuy Synthes Products, Inc. | Method and apparatus for resurfacing an articular surface |
| EP1529543A1 (fr) * | 2003-11-04 | 2005-05-11 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Utilisation d'un hydrogel pour la culture de chondrocytes |
| US7316822B2 (en) | 2003-11-26 | 2008-01-08 | Ethicon, Inc. | Conformable tissue repair implant capable of injection delivery |
| US7901461B2 (en) | 2003-12-05 | 2011-03-08 | Ethicon, Inc. | Viable tissue repair implants and methods of use |
| EP1701672A4 (en) | 2003-12-19 | 2011-04-27 | Osteotech Inc | TISSUE-BASED MESH FOR BONE REGENERATION |
| US8012210B2 (en) | 2004-01-16 | 2011-09-06 | Warsaw Orthopedic, Inc. | Implant frames for use with settable materials and related methods of use |
| FR2865939B1 (fr) * | 2004-02-06 | 2007-08-31 | Biomatlante | Utilisation de polymeres organiques silanises pour creation de revetement bioactif, pour implant ou prothese |
| US11395865B2 (en) | 2004-02-09 | 2022-07-26 | DePuy Synthes Products, Inc. | Scaffolds with viable tissue |
| US8657881B2 (en) | 2004-04-20 | 2014-02-25 | Depuy Mitek, Llc | Meniscal repair scaffold |
| US8137686B2 (en) | 2004-04-20 | 2012-03-20 | Depuy Mitek, Inc. | Nonwoven tissue scaffold |
| US8221780B2 (en) | 2004-04-20 | 2012-07-17 | Depuy Mitek, Inc. | Nonwoven tissue scaffold |
| US20060233849A1 (en) * | 2005-04-13 | 2006-10-19 | Simon Bruce J | Composite bone graft material |
| US7621963B2 (en) * | 2005-04-13 | 2009-11-24 | Ebi, Llc | Composite bone graft material |
| DE102005024296B4 (de) * | 2005-05-19 | 2007-02-01 | Bundesanstalt für Materialforschung und -Prüfung (BAM) | Resorbierbarer, biokompatibler Formkörper und Verfahren zur Herstellung |
| AU2007207495A1 (en) | 2006-01-19 | 2007-07-26 | Warsaw Orthopedic, Inc. | Porous osteoimplant |
| EP1976460A4 (en) | 2006-01-19 | 2012-06-20 | Warsaw Orthopedic Inc | INJECTABLE AND FORMABLE BONE REPLACEMENT MATERIALS |
| FR2913199B1 (fr) | 2007-03-01 | 2009-05-08 | Biomatlante Sarl | Composition granulaire deshydratee et ses applications biomedicales. |
| WO2008136733A1 (en) * | 2007-05-04 | 2008-11-13 | Ascendia Ab | Method and means for culturing osteoblastic cells |
| WO2009105614A2 (en) * | 2008-02-22 | 2009-08-27 | Dermal Technologies, Llc | Compositions for tissue augmentation |
| CN102036612B (zh) * | 2008-03-28 | 2014-08-06 | 骨科技术公司 | 用于整形外科应用的骨锚 |
| FR2936801A1 (fr) * | 2008-10-03 | 2010-04-09 | Centre Nat Rech Scient | Procede de silanisation de polysaccharides. |
| AU2009317974A1 (en) * | 2008-10-30 | 2010-05-27 | Vanderbilt University | Bone/polyurethane composites and methods thereof |
| WO2012134540A2 (en) | 2010-10-22 | 2012-10-04 | Vanderbilt University | Injectable synthetic pur composite |
| CN103242846B (zh) * | 2012-02-10 | 2016-01-13 | 海洋王照明科技股份有限公司 | 钛磷酸盐发光薄膜、其制备方法及电致发光器件 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8402534A (nl) * | 1984-08-17 | 1986-03-17 | Gerrit Johannes Brinks | Materiaal, geschikt voor toepassing als implantatiemateriaal bij mens en dier ter vervanging van afwezig botweefsel, alsmede werkwijze ter bereiding van het materiaal. |
| JP2877840B2 (ja) * | 1989-06-08 | 1999-04-05 | 三金工業株式会社 | 生体硬組織用セメント材料 |
| JP2621622B2 (ja) * | 1990-09-27 | 1997-06-18 | 三菱マテリアル株式会社 | 水硬性リン酸カルシウムセメント |
| EP0511868B1 (en) * | 1991-05-01 | 1996-09-25 | Chichibu Onoda Cement Corporation | Medical or dental hardening compositions |
| FR2715853B1 (fr) * | 1994-02-08 | 1996-04-26 | Centre Nat Rech Scient | Composition pour bio-matériau; procédé de préparation. |
-
1995
- 1995-08-07 FR FR9509582A patent/FR2737663B1/fr not_active Expired - Fee Related
-
1996
- 1996-07-29 JP JP50793097A patent/JP3597541B2/ja not_active Expired - Lifetime
- 1996-07-29 PT PT96927103T patent/PT843562E/pt unknown
- 1996-07-29 CA CA002226304A patent/CA2226304C/fr not_active Expired - Lifetime
- 1996-07-29 AT AT96927103T patent/ATE214292T1/de active
- 1996-07-29 WO PCT/FR1996/001196 patent/WO1997005911A1/fr active IP Right Grant
- 1996-07-29 AU AU67042/96A patent/AU707039B2/en not_active Expired
- 1996-07-29 ES ES96927103T patent/ES2173306T3/es not_active Expired - Lifetime
- 1996-07-29 EP EP96927103A patent/EP0843562B1/fr not_active Expired - Lifetime
- 1996-07-29 DK DK96927103T patent/DK0843562T3/da active
- 1996-07-29 DE DE69619830T patent/DE69619830T2/de not_active Expired - Lifetime
- 1996-07-29 US US09/011,215 patent/US6001394A/en not_active Expired - Lifetime
- 1996-08-05 ZA ZA9606635A patent/ZA966635B/xx unknown
-
1998
- 1998-02-05 NO NO19980504A patent/NO311604B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997005911A1 (fr) | 1997-02-20 |
| FR2737663A1 (fr) | 1997-02-14 |
| DK0843562T3 (da) | 2002-05-21 |
| JP3597541B2 (ja) | 2004-12-08 |
| AU707039B2 (en) | 1999-07-01 |
| ATE214292T1 (de) | 2002-03-15 |
| JPH11510076A (ja) | 1999-09-07 |
| CA2226304C (fr) | 2007-01-09 |
| FR2737663B1 (fr) | 1997-10-03 |
| ES2173306T3 (es) | 2002-10-16 |
| NO980504L (no) | 1998-04-06 |
| US6001394A (en) | 1999-12-14 |
| EP0843562A1 (fr) | 1998-05-27 |
| DE69619830T2 (de) | 2002-09-12 |
| PT843562E (pt) | 2002-08-30 |
| CA2226304A1 (fr) | 1997-02-20 |
| NO980504D0 (no) | 1998-02-05 |
| DE69619830D1 (de) | 2002-04-18 |
| EP0843562B1 (fr) | 2002-03-13 |
| ZA966635B (en) | 1998-02-05 |
| AU6704296A (en) | 1997-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO311604B1 (no) | Blanding for biomaterial og fremgangsmåte for fremstilling derav | |
| EP0224545B1 (en) | Pharmaceutical depot preparation | |
| Lee et al. | Induction of osteogenic differentiation in a rat calvarial bone defect model using an In situ forming graphene oxide incorporated glycol chitosan/oxidized hyaluronic acid injectable hydrogel | |
| Vinatier et al. | Cartilage and bone tissue engineering using hydrogels | |
| EP1981556B1 (en) | Bone graft and scaffolding materials immobilized with type i collagen binding peptides | |
| FR2715853B1 (fr) | Composition pour bio-matériau; procédé de préparation. | |
| JP2665385B2 (ja) | 精製粒子状骨鉱質生成物 | |
| WO2009029049A1 (en) | A bone and/or dental cement composition and uses thereof | |
| CA2164045A1 (en) | Hard tissue bone cements and substitutes | |
| EP0389629B1 (en) | Medical and dental curable material | |
| EP2540277B1 (en) | Kit for adhering biological hard tissues | |
| KR20150126669A (ko) | 인간 ｂｍｐ-2 단백질의 모방 펩티드에 의해 이식된 골 대체재 | |
| EP4121132A1 (en) | Method for producing hydroxyapatite-bioglass materials, said materials and products thereof | |
| Turczyn et al. | In situ self hardening bioactive composite for bone and dental surgery | |
| Ohtsuki et al. | Design of novel bioactive materials through organic modification of calcium silicate | |
| JPH06304242A (ja) | コラーゲン−リン酸カルシウム複合材料およびその用途 | |
| CN102892385A (zh) | 包含二羟基苯甲酸衍生物的骨移植用或骨填充用组合物 | |
| JP2014124416A (ja) | 骨再生材料キット、ペースト状骨再生材料、骨再生材料及び骨接合材 | |
| RU2804689C2 (ru) | Способ получения композиционного гидрогеля, формирующегося in situ для замещения костно-хрящевых дефектов | |
| KR20230108930A (ko) | 인산칼슘계 골 이식재 조성물 | |
| Goenka et al. | Development of guar gum reinforced calcium magnesium phosphate‐based bone biocement | |
| CN118141980A (zh) | 一种选择性抑制纤维组织生长的可注射骨水泥及其制备方法和应用 | |
| Kashiwazaki et al. | In vivo evaluation of a novel chitosan/HAp composite biomaterial as a carrier of rhBMP-2 | |
| Lee et al. | Kyoung-Hwa Kim: Resources | |
| Temenoff | Development of thermally-crosslinked hydrogels as injectable cell carriers for orthopaedic tissue engineering |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |